Derivative action assessment for cross-border shareholders

A derivative action assessment establishes whether a shareholder in a group structure has standing to bring a claim on the company's behalf. It also asks whether the board's own response to the alleged wrong has already closed off that route. The question arises most often when a minority investor in a foreign-owned subsidiary believes the directors caused loss to the company and the board will not sue on its own account. Getting the assessment right before any claim is filed decides which forum can hear it and what the board needs on file to show the wrong was considered in good faith.

A private equity fund holds a minority stake in an operating company registered outside its home market. The fund's board representative raises a related-party transaction that appears to benefit the majority shareholder's other interests. The remaining directors decline to investigate. The fund's counsel then has to work out whether it can sue the directors on the company's behalf, in which forum, and whether raising the matter at board level first was a required step.

This page sets out when a derivative action assessment is needed, what the assessment produces, and where the analysis differs by jurisdiction. The position differs enough between legal traditions that jurisdiction-specific detail sits on its own page; the assessment for companies in the Abu Dhabi Global Market is one worked example of that.

The situation a derivative action assessment addresses

The problem rarely starts with the shareholder. It starts with a board that has stopped functioning as a check on itself: a related-party contract nobody outside the boardroom can see, a subsidiary director who also sits on the board of the counterparty, or a parent company routing value away from a joint venture into the parent's own subsidiary. Whether the minority shareholder's remedy survives depends on facts the shareholder usually does not control.

Cross-border groups add a second layer. The company whose board misbehaved may sit in one jurisdiction, its parent in another, and the shareholder bringing the claim in a third. Corporate governance rules determine who may sue on the company's behalf. They are set at the level of the company's own jurisdiction, not at the level of the group structure as a whole. A derivative action assessment therefore has to work out, jurisdiction by jurisdiction, whether shareholder rights survive being routed through a holding structure. It also has to establish whether disclosure of the beneficial owner behind the claim changes anything about standing. This work often runs alongside an information rights enforcement claim, since the shareholder needs the underlying documents before standing can be assessed at all.

The situations that most often prompt the question include the following.

• A board refusing to pursue a claim the shareholder believes is clearly available.
• A majority shareholder using its board control to ratify its own prior conduct.
• A minority investor discovering, late, that a decision it never saw is now final on the company's register.

What triggers the need for a derivative action assessment

The trigger is rarely the wrong itself. It is the board's response to it, or the absence of one. A shareholder who raises a related-party transaction and receives silence, or a curt refusal to investigate, is at the point where the assessment becomes urgent rather than optional.

Timing has a hard edge in most systems that recognise a derivative claim at all. Once the alleged wrong has been ratified by the shareholders who control the vote, the door narrows. The same is true once a limitation period tied to the date the wrong became discoverable has run. A resolution ratifying the board's conduct, once filed with the company's own register, becomes part of the permanent record. It can be corrected by a further filing but not withdrawn, and that closes off the argument that the wrong was never sanctioned by the company itself.

The other trigger is structural rather than procedural: a change of control, a refinancing, or an exit process where the buyer's own lawyers will ask whether any shareholder holds an outstanding claim against the target's directors. A derivative action assessment review at that stage answers the question before the buyer's diligence team asks it less charitably.

A demand letter that lands on a board's desk without a standing assessment behind it usually gets answered by the board's own lawyers within days. Once it is answered on the record, the shareholder has lost the advantage of surprise. If the demand has already gone out, or is about to, the assessment needs to run alongside the board's response, not after it.

Assess your director exposure Write to info@hreithlaw.com with the jurisdiction and the structure.

What the assessment produces, in sequence

The work follows a fixed sequence, because each step depends on the one before it.

1. A standing memorandum setting out, jurisdiction by jurisdiction, who is entitled to bring a claim on the company's behalf and on what conditions.
2. A demand-and-ratification review: whether the wrong has already been put to the shareholders, and what that vote is capable of curing if it has.
3. A shareholder rights matrix comparing the position in the company's own jurisdiction against the jurisdiction where the loss was actually suffered.
4. A board pack setting out the questions the directors need to resolve, and the record they need to keep, before responding to the shareholder's demand.
5. An evidentiary file collecting the documents a court or tribunal will expect to see if the claim proceeds.

Each deliverable is written to be used, not filed away. The standing memorandum answers whether the claim exists at all. The board pack answers what the directors do next, and it draws on the same analysis set out separately on what board resolutions a derivative action assessment typically requires. Neither document is much use without the other.

Where the analysis differs by jurisdiction

The underlying question, whether this shareholder can sue on the company's behalf, is answered differently depending on the legal tradition the company sits in. The assessment has to track that difference rather than assume a single global standard.

In some offshore companies the constitution goes further and restricts transfer of the shares themselves, which can change who holds standing in the first place; see the position on articles restricting share transfers in the Cayman Islands. A side-by-side comparison of minority remedies in the Abu Dhabi Global Market, Delaware and the United States shows how far the leave requirement itself can differ between systems that look similar on paper.

Groups that hold the operating company through several layers face a second question on top of the first: whether the shareholder needs to have held its interest for a minimum period before the alleged wrong occurred. The clock on any limitation period usually runs from the date the wrong became known to the shareholder, not the date it occurred. Once that period has run, the remedy ceases to be available, regardless of how strong the underlying claim is.

What this service does not include

A derivative action assessment does not include acting as, supplying, sourcing or arranging a director, a company secretary, a nominee shareholder or a trustee for the company under review. It does not include any activity for which a trust or corporate service provider licence is required, including standing in for an officer of the company while the dispute is live.

The boundary is a licensing question, not a preference. Advising on whether a director's conduct exposes them personally, and stepping into that director's seat, are regulated differently in most of the jurisdictions covered here. The second is not something this practice is authorised to do. What the engagement provides instead is the standing question mapped to the company's own jurisdiction, the demand-and-ratification position tested against the board's own minutes, and an evidentiary file the board can rely on if the claim proceeds.

Once a board has ratified a related-party transaction, the shareholder's remaining options usually narrow to whether the directors who benefited can be pursued personally. That question has to be answered before any settlement discussion starts, not during one.

Assess your director exposure Write to info@hreithlaw.com with the jurisdiction and the structure.

Frequently asked questions

Does derivative action assessment change for a foreign-owned company?

Yes. The company's own jurisdiction still sets who can sue on its behalf, but a foreign parent adds a question about whether the parent's own approval of the conduct counts as ratification. That question has to be answered separately from the standing question itself.

What does derivative action assessment require in practice?

It requires the board's minutes, the constitution, the register entries relevant to ownership and any prior shareholder resolutions touching the alleged wrong. Without those documents the standing question cannot be tested, which is why the assessment often runs alongside a separate request for records.

Who inside the company is responsible for derivative action assessment?

No single officer owns this by default. The board as a whole is the body that decides whether to pursue the claim itself, and the assessment is usually commissioned by whichever director or shareholder first raises the question, not assigned by title.

What evidence should the board keep on derivative action assessment?

A written record of when the alleged wrong was raised, what the board considered, and why it decided as it did. A board that can point to a dated, reasoned decision is in a materially different position from one that simply stayed silent.

What happens if derivative action assessment is not addressed?

The shareholder may act on an assumption about standing that turns out to be wrong once a claim is filed, and the board may ratify conduct without realising the ratification itself closes off a later argument. Both outcomes are avoidable, and both are cheaper to avoid before a filing than after one.